LA, A., MB, S., SH, S. E., NM, E., HO, A., SM, N., . . . S, S. (2020). Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways. European journal of pharmacology, 887, 173461. https://doi.org/10.1016/j.ejphar.2020.173461
Chicago Style (17th ed.) CitationLA, Ahmed, Salem MB, Seif El-Din SH, El-Lakkany NM, Ahmed HO, Nasr SM, Hammam OA, Botros SS, and Saleh S. "Gut Microbiota Modulation as a Promising Therapy with Metformin in Rats with Non-alcoholic Steatohepatitis: Role of LPS/TLR4 and Autophagy Pathways." European Journal of Pharmacology 887 (2020): 173461. https://doi.org/10.1016/j.ejphar.2020.173461.
MLA (9th ed.) CitationLA, Ahmed, et al. "Gut Microbiota Modulation as a Promising Therapy with Metformin in Rats with Non-alcoholic Steatohepatitis: Role of LPS/TLR4 and Autophagy Pathways." European Journal of Pharmacology, vol. 887, 2020, p. 173461, https://doi.org/10.1016/j.ejphar.2020.173461.
